Showing results (2281-2290 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|November 30, 2020
An Illustrative Case of Combination Cabozantinib/Nivolumab for Progressive Metastatic Renal Cell Carcinoma (mRCC)Chester Kao, Daniel J George, Tian Zhang
The Oncologist|November 30, 2020
Assessing the Quality of Care Delivered to Transgender and Gender Diverse Patients with Cancer in Ireland: A Case SeriesCarolyn Moloney, Margaret Allen, Derek G Power, et al.
The Oncologist|November 30, 2020
Edmonton Symptom Assessment Scale Time Duration of Self-Completion Versus Assisted Completion in Patients with Advanced Cancer: A Randomized ComparisonAngelique Wong, Supakarn Tayjasanant, Alfredo Rodriguez-Nunez, et al.
The Oncologist|December 28, 2020
Heterogeneity in Quality of Life of Long-Term Colon Cancer Survivors: A Latent Class Analysis of the Population-Based PROFILES RegistryFelix J Clouth, Arturo Moncada-Torres, Gijs Geleijnse, et al.
The Oncologist|December 4, 2020
Tumor Response and Symptom Palliation from RAINBOW, a Phase III Trial of Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric CancerStefano Cascinu, György Bodoky, Kei Muro, et al.
The Oncologist|December 8, 2020
Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or OxaliplatinRudolph M Navari, Kathryn J Ruddy, Thomas W LeBlanc, et al.
The Oncologist|December 10, 2020
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%?Elettra Merola, Teresa Alonso Gordoa, Panpan Zhang, et al.
The Oncologist|December 4, 2020
Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and CaveatsCasey O'Connell, Carmen P Escalante, Samuel Z Goldhaber, et al.
The Oncologist|September 27, 2022
TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell TumorsJack V W Bacon, Patrizia Giannatempo, Giovanna Cataldo, et al.
The Oncologist|March 22, 2021
Safety and Efficacy of Cetuximab-Based Salvage Chemotherapy After Checkpoint Inhibitors in Head and Neck CancerSantiago Cabezas-Camarero, María Nieves Cabrera-Martín, Salomé Merino-Menéndez, et al.
Pageof 571